Cronos Group Inc. (NASDAQ:CRON) Receives $2.30 Consensus PT from Brokerages

Cronos Group Inc. (NASDAQ:CRON) has received a consensus rating of “Hold” from the five brokerages that are covering the firm, Marketbeat.com reports. Three investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 12-month price target among brokerages that have covered the stock in the last year is $2.30.

Several equities research analysts recently issued reports on CRON shares. Wall Street Zen raised shares of Cronos Group from a “sell” rating to a “hold” rating in a research note on Saturday, February 14th. Weiss Ratings restated a “hold (c)” rating on shares of Cronos Group in a report on Monday, December 29th. Canaccord Genuity Group assumed coverage on Cronos Group in a research report on Tuesday, January 27th. They issued a “buy” rating on the stock. Zacks Research cut Cronos Group from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, January 6th. Finally, Sanford C. Bernstein restated a “market perform” rating and issued a $2.30 price target on shares of Cronos Group in a research note on Wednesday, January 14th.

Cronos Group Stock Performance

Shares of NASDAQ:CRON opened at $2.67 on Tuesday. The business’s 50-day simple moving average is $2.65 and its 200 day simple moving average is $2.60. The company has a market cap of $1.02 billion, a P/E ratio of 26.70 and a beta of 0.80. Cronos Group has a one year low of $1.60 and a one year high of $3.43.

Cronos Group (NASDAQ:CRON) last issued its quarterly earnings data on Thursday, February 26th. The company reported $0.02 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.01 by $0.01. Cronos Group had a net margin of 27.27% and a negative return on equity of 1.12%. The company had revenue of $58.39 million during the quarter, compared to the consensus estimate of $38.51 million. Analysts predict that Cronos Group will post -0.03 earnings per share for the current year.

Hedge Funds Weigh In On Cronos Group

Large investors have recently modified their holdings of the stock. Quinn Opportunity Partners LLC increased its holdings in Cronos Group by 73.0% in the second quarter. Quinn Opportunity Partners LLC now owns 7,437,944 shares of the company’s stock valued at $14,206,000 after buying an additional 3,138,018 shares during the last quarter. Tidal Investments LLC increased its holdings in shares of Cronos Group by 5.3% in the 2nd quarter. Tidal Investments LLC now owns 5,653,070 shares of the company’s stock valued at $10,797,000 after acquiring an additional 282,356 shares during the last quarter. MMCAP International Inc. SPC raised its position in shares of Cronos Group by 56.1% during the 4th quarter. MMCAP International Inc. SPC now owns 2,761,059 shares of the company’s stock valued at $7,262,000 after acquiring an additional 991,977 shares in the last quarter. Dimensional Fund Advisors LP lifted its stake in Cronos Group by 1.3% during the fourth quarter. Dimensional Fund Advisors LP now owns 2,506,210 shares of the company’s stock worth $6,591,000 after purchasing an additional 32,202 shares during the last quarter. Finally, Renaissance Technologies LLC boosted its holdings in Cronos Group by 4.0% in the fourth quarter. Renaissance Technologies LLC now owns 1,845,049 shares of the company’s stock worth $4,852,000 after purchasing an additional 70,500 shares during the period. Institutional investors own 8.71% of the company’s stock.

Key Cronos Group News

Here are the key news stories impacting Cronos Group this week:

• Positive Sentiment: Q4 earnings beat consensus — Cronos reported $0.02 EPS vs. street $0.01 and outperformed revenue expectations, which supports near-term sentiment and valuation re-rating. MarketBeat Earnings Report
• Positive Sentiment: Top-line growth and strong liquidity — company reported record Q4 net revenue (+47% YoY) and FY revenue growth, with an industry-leading balance sheet (reported ~$832M in cash & short-term investments), which reduces financing risk and funds expansion. GlobeNewswire Press Release
• Positive Sentiment: Analyst/idea coverage highlights growth runway — a recent Seeking Alpha piece notes geographic expansion (Europe, Australia), acquisitions and capacity gains as drivers for margin and revenue improvement over 24–36 months, supporting a bullish case at current valuation. Seeking Alpha Bullish Analysis
• Neutral Sentiment: Short-interest data appears inconsistent/glitched in recent release (reported as zero); no clear signal from short-interest trends to explain intraday moves.
• Negative Sentiment: Foreign-exchange losses drove the quarter to a GAAP loss and produced negative headlines — coverage cites FX swings as the main drag on results, which is likely contributing to downward pressure on the stock despite the operational beats. Seeking Alpha: FX Losses MarketWatch: FX Impact

About Cronos Group

Cronos Group Inc is a Canadian cannabinoid company dedicated to the cultivation, production and distribution of cannabis and cannabidiol (CBD) products for both medical and adult-use markets. Headquartered in Toronto, Ontario, the company manages operations that span the full cannabis value chain, including breeding, greenhouse cultivation, extraction, product formulation and packaging. Cronos Group’s business model emphasizes innovation in product development and scalability in manufacturing to meet evolving regulatory and consumer demands.

The company’s branded portfolio includes Peace Naturals, which focuses on pharmaceutical-grade medical cannabis; Spinach, a line of adult-use cannabis oils and tinctures; and Cove, a range of wellness-oriented CBD offerings.